Biocompatibility of Intracanal Medications Based on Calcium Hydroxide

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="left">Composition</td><td align="left">Manufacturer</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Calen</td><td align="left">49.77% calcium hydroxide, <br/>50.23% of zinc oxide, colophony, and polyethylene glycol 400</td><td align="left">S. S. White Artigos Dentários Ltda., Rio de Janeiro, RJ, Brazil</td></tr><tr><td align="left" colspan="3"><hr/></td></tr><tr><td align="left">UltraCal XS</td><td align="left">35% calcium hydroxide and a radiopacifier</td><td align="left">Ultradent Products, Inc., South Jordan, UT, USA</td></tr><tr><td align="left" colspan="3"><hr/></td></tr><tr><td align="left">Hydropast</td><td align="left">38% of calcium hydroxide, 62% of barium oxide, and propilenoglicol</td><td align="left">Biodinamica Quimica e Farmaceutica Ltda., Ibipora, PR, Brazil</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Scholarly Research Notices

tab1

Table 1

Table 1: Biocompatibility of Intracanal Medications Based on Calcium Hydroxide 